318 related articles for article (PubMed ID: 10851367)
21. The Elusive Nature of APOE ε4 in Mid-adulthood: Understanding the Cognitive Profile.
Lancaster C; Tabet N; Rusted J
J Int Neuropsychol Soc; 2017 Mar; 23(3):239-253. PubMed ID: 28059047
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
23. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
24. APOE genotype modifies the association between central arterial stiffening and cognition in older adults.
Cambronero FE; Liu D; Neal JE; Moore EE; Gifford KA; Terry JG; Nair S; Pechman KR; Osborn KE; Hohman TJ; Bell SP; Sweatt JD; Wang TJ; Beckman JA; Carr JJ; Jefferson AL
Neurobiol Aging; 2018 Jul; 67():120-127. PubMed ID: 29656011
[TBL] [Abstract][Full Text] [Related]
25. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
26. Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly.
Luck T; Then FS; Luppa M; Schroeter ML; Arélin K; Burkhardt R; Thiery J; Löffler M; Villringer A; Riedel-Heller SG
Neuropsychology; 2015 May; 29(3):382-387. PubMed ID: 25365563
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
[TBL] [Abstract][Full Text] [Related]
28. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
[TBL] [Abstract][Full Text] [Related]
29. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.
Caselli RJ; Graff-Radford NR; Reiman EM; Weaver A; Osborne D; Lucas J; Uecker A; Thibodeau SN
Neurology; 1999 Jul; 53(1):201-7. PubMed ID: 10408560
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
Bondi MW; Salmon DP; Galasko D; Thomas RG; Thal LJ
Psychol Aging; 1999 Jun; 14(2):295-303. PubMed ID: 10403716
[TBL] [Abstract][Full Text] [Related]
31. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
Klages J; Fisk JD
Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
[TBL] [Abstract][Full Text] [Related]
32. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
33. The effect of the APOE-epsilon4 allele and ACE-I/D polymorphism on cognition during a two-year follow-up in first-ever stroke patients.
Bour AM; Rasquin SM; Baars L; van Boxtel MP; Visser PJ; Limburg M; Verhey FR
Dement Geriatr Cogn Disord; 2010; 29(6):534-42. PubMed ID: 20606435
[TBL] [Abstract][Full Text] [Related]
34. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
[TBL] [Abstract][Full Text] [Related]
35. The influence of APOE status on episodic and semantic memory: data from a population-based study.
Nilsson LG; Adolfsson R; Bäckman L; Cruts M; Nyberg L; Small BJ; Van Broeckoven C
Neuropsychology; 2006 Nov; 20(6):645-57. PubMed ID: 17100509
[TBL] [Abstract][Full Text] [Related]
36. Association between ApoE epsilon4 and cognitive impairment after stroke.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
[TBL] [Abstract][Full Text] [Related]
37. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.
Carmelli D; DeCarli C; Swan GE; Kelly-Hayes M; Wolf PA; Reed T; Guralnik JM
J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):M103-9. PubMed ID: 10737693
[TBL] [Abstract][Full Text] [Related]
38. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults.
Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu TT; Helm JL; Wierenga CE
Neuroimage; 2019 Nov; 202():116162. PubMed ID: 31493534
[TBL] [Abstract][Full Text] [Related]
39. Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample.
Oberlin LE; Manuck SB; Gianaros PJ; Ferrell RE; Muldoon MF; Jennings JR; Flory JD; Erickson KI
Neuropsychology; 2015 Sep; 29(5):693-702. PubMed ID: 25730733
[TBL] [Abstract][Full Text] [Related]
40. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
